http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2012116127-A

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-403
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-401
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-551
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D209-42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-675
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D207-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-403
filingDate 2010-09-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2013-10-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber RU-2012116127-A
titleOfInvention NEW GASOLINE SALTS OF ACE INHIBITORS, METHOD FOR PRODUCING THEM AND THEIR APPLICATION FOR TREATMENT OF CARDIOVASCULAR DISEASES
abstract 1. Salts of ACE inhibitors with N, N'-dibenzylethylenediamine (benzathine) of the general formula: where ACE is an ACE inhibitor molecule, and these salts exist in amorphous and crystalline forms. 2. Perindopril benzatin salt in crystalline polymorphic form A with the following X-ray powder diffraction pattern: 3. Perindopril benzatin salt in crystalline polymorphic form B with the following x-ray powder diffraction pattern: 4. Perindopril benzatin salt in amorphous form. 5. Fosinopril benzatin salt in crystalline form with the following X-ray powder diffraction pattern: 6. Enalapril benzatin salt in crystalline form with the following x-ray powder diffraction pattern: 7. Ramipril benzatin salt in crystalline form with the following X-ray powder diffraction pattern: 8. Cilazapril benzatin salt in crystalline form with the following X-ray powder diffraction pattern: 9. A method for producing benzatine salts of ACE inhibitors of the general formula: by the interaction of two moles of ACE inhibitors with one mole of N, N'-dibenzylethylenediamine. 10. The method of producing benzathine salts in crystalline form according to claim 9, characterized in that during crystallization, water or an organic solvent selected from the group consisting of esters, lower alcohols, ketones, nitriles or ethers, preferably ethyl acetate, acetone, is used as a solvent. , ethanol, acetonitrile and methyl tert-butyl ether. 11. The method for producing the benzathine salts of ACE inhibitors in amorphous form according to claim 9, characterized in that a solution of benzathine salt in water is obtained
priorityDate 2009-09-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID180
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559506
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8793
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448970460
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21584533
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559052
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID15413
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419513968
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559261
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9601226
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID271
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21885917
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8857
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419537701
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451878892
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426147843
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419536333
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21585056
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449522968
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID56330
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419491948
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538408
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3283
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID107807

Total number of triples: 45.